Molecular mechanisms for insulin resistance in treated HIV-infection

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 25, Issue 3, 2011, Pages 459-468

  Hruz, Paul W ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Campus Box 8208 ^*  (United States)

Author keywords

adipocytokines; ER stress; glucose transport; HIV protease inhibitors; in vitro models; insulin sensitivity; lipotoxicity; nucleoside reverse transcriptase inhibitors

Indexed keywords

ADIPOCYTOKINE; ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; CYTOKINE RELEASE; DRUG SAFETY; ENDOPLASMIC RETICULUM; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; LIPOTOXICITY; METABOLIC SYNDROME X; NONHUMAN; OXIDATIVE STRESS;

EID: 79958246325     PISSN: 1521690X     EISSN: 15321908     Source Type: Journal    
DOI: 10.1016/j.beem.2010.10.017     Document Type: Review

References (84)

1. A.A. Butt, K. McGinnis, and M.C. Rodriguez-Barradas HIV infection and the risk of diabetes mellitus AIDS 23 2009 1227 1234
2. T.T. Brown, S.R. Cole, and X. Li Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study Archives of Internal Medicine 165 2005 1179 1184 (Pubitemid 40720744)
3. S. Galic, J.S. Oakhill, and G.R. Steinberg Adipose tissue as an endocrine organ Molecular and Cellular Endocrinology 316 2010 129 139
4. K.D. Bruce, and C.D. Byrne The metabolic syndrome: common origins of a multifactorial disorder Postgraduate Medical Journal 85 2009 614 621
5. D. Chen, A. Misra, and A. Garg Clinical review 153: lipodystrophy in human immunodeficiency virus-infected patients The Journal of Clinical Endocrinology and Metabolism 87 2002 4845 4856 (Pubitemid 35331060)
6. P. Dowell, C. Flexner, and P.O. Kwiterovich Suppression of preadipocyte differentiation and Promotion of adipocyte Death by HIV protease inhibitors The Journal of Biological Chemistry 275 2000 41325 41332 (Pubitemid 32054966)
7. R.J. Kim, C.G. Wilson, and M. Wabitsch HIV protease inhibitor-specific alterations in human adipocyte differentiation and metabolism[ast] Obesity 14 2006 994 1002 (Pubitemid 46219700)
8. J.M. Lenhard, E.S. Furfine, and R.G. Jain HIV protease inhibitors block adipogenesis and increase lipolysis in vitro Antiviral Research 47 2000 121 129
9. B. Zhang, K. Macnaul, and D. Szalkowski Inhibition of adipocyte differentiation by HIV protease inhibitors Journal of Clinical Endocrinology and Metabolism 84 1999 4274 4277 (Pubitemid 30644229)
10. J.P. Bastard, M. Caron, and H. Vidal Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance Lancet 359 2002 1026 1031 (Pubitemid 34286541)
11. M. Caron, M. Auclair, and C. Vigouroux The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance Diabetes 50 2001 1378 1388 (Pubitemid 32500171)
12. R. Minami, M. Yamamoto, and S. Takahama Comparison of the influence of four classes of HIV antiretrovirals on adipogenic differentiation: the minimal effect of raltegravir and atazanavir Journal of Infection and Chemotherapy 2010
13. C. Coffinier, S.E. Hudon, and E.A. Farber HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells PNAS 104 2007 13432 13437 (Pubitemid 47293962)
14. C.N. Goulbourne, and D.J. Vaux HIV protease inhibitors inhibit FACE1/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy? Biochemical Society Transactions 38 2010 292 296
15. M. Caron, M. Auclair, and H. Sterlingot Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation AIDS 17 2003 2437 2444 (Pubitemid 38393315)
16. A.K. Agarwal, J.P. Fryns, and R.J. Auchus Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia Human Molecular Genetics 12 2003 1995 2001 (Pubitemid 37038808)
17. V. Simha, and A. Garg Lipodystrophy: lessons in lipid and energy metabolism Current Opinion in Lipidology 17 2006 162 169
18. A. Garg, and A. Misra Lipodystrophies: rare disorders causing metabolic syndrome Endocrinology and Metabolism Clinics of North America 33 2004 305 331 (Pubitemid 38680632)
19. V.T. Samuel, K.F. Petersen, and G.I. Shulman Lipid-induced insulin resistance: unravelling the mechanism Lancet 375 2010 2267 2277
20. E.A. Oral, and J.L. Chan Rationale for leptin-replacement therapy for severe lipodystrophy Endocrine Practice 16 2010 324 333
21. K. Mulligan, H. Khatami, and J.M. Schwarz The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia The Journal of Clinical Endocrinology and Metabolism 94 2009 1137 1144
22. B.L. Wajchenberg Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome Endocrine Reviews 21 2000 697 738 (Pubitemid 32113289)
23. Q. He, E.S. Engelson, and J.B. Albu Preferential loss of omental-mesenteric fat during growth hormone therapy of HIV-associated lipodystrophy Journal of Applied Physiology 94 2003 2051 2057 (Pubitemid 36457459)
24. H. Murata, P.W. Hruz, and M. Mueckler The mechanism of insulin resistance caused by HIV protease inhibitor therapy Journal of Biological Chemistry 275 2000 20251 20254 (Pubitemid 30457596)
25. H. Murata, P.W. Hruz, and M. Mueckler Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations AIDS 16 2002 859 863 (Pubitemid 34409009)
26. J. Hertel, H. Struthers, and C.B. Horj A structural basis for the acute effects of HIV protease inhibitors on GLUT4 intrinsic activity Journal of Biological Chemistry. 279 2004 55147 55152 (Pubitemid 40066508)
27. P.W. Hruz, and Q. Yan Tipranavir without ritonavir does not acutely induce peripheral insulin resistance in a rodent model Journal of Acquired Immune Deficiency Syndromes 43 2006 624 625 (Pubitemid 44885632)
28. Q. Yan, and P.W. Hruz Direct comparison of the acute in vivo effects of HIV protease inhibitors on peripheral glucose disposal Journal of Acquired Immune Deficiency Syndromes 40 2005 398 403 (Pubitemid 41669172)
29. R. Ben-Romano, A. Rudich, and D. Torok Agent and cell-type specificity in the induction of insulin resistance by HIV protease inhibitors AIDS 17 2003 23 32 (Pubitemid 36106295)
30. P. Algenstaedt, S. Daneshi, and B. Schwarzloh Therapeutic dose of HIV-1 protease inhibitor saquinavir does not permanently influence early insulin signaling Experimental and Clinical Endocrinology & Diabetes 111 2003 491 498 (Pubitemid 38101495)
31. R. Ben-Romano, A. Rudich, and A. Tirosh Nelfinavir-induced insulin resistance is associated with impaired plasma membrane recruitment of the PI 3-kinase effectors Akt/PKB and PKC-zeta Diabetologia 47 2004 1107 1117 (Pubitemid 38918171)
32. R. Ben-Romano, A. Rudich, and S. Etzion Nelfinavir induces adipocyte insulin resistance through the induction of oxidative stress: differential protective effect of antioxidant agents Antiviral Therapy 11 2006 1051 1060 (Pubitemid 44955181)
33. M.J. Carper, W.T. Cade, and M. Cam HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus American Journal of Physiology - Endocrinology And Metabolism 294 2008 E558 E567
34. W.P. Cawthorn, and J.K. Sethi TNF-alpha and adipocyte biology FEBS Letters 582 2008 117 131
35. T.T. Brown, K. Tassiopoulos, and R.J. Bosch Association between systemic inflammation and incident diabetes mellitus in HIV-infected patients after initiation of antiretroviral therapy Diabetes Care 2010
36. H. Tilg, and A.R. Moschen Inflammatory mechanisms in the regulation of insulin resistance Molecular Medicine 14 2008 222 231 (Pubitemid 351481853)
37. B. Qin, R.A. Anderson, and K. Adeli Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling American Journal of Physiology - Gastrointestinal and Liver Physiology 294 2008 G1120 G1129
38. G.S. Hotamisligil Endoplasmic reticulum stress and the inflammatory basis of metabolic disease Cell 140 2010 900 917
39. R.A. Parker, O.P. Flint, and R. Mulvey Endoplasmic reticulum stress links dyslipidemia to inhibition of proteasome activity and glucose transport by HIV protease inhibitors Molecular Pharmacology 67 2005 1909 1919 (Pubitemid 41007773)
40. A. Maagaard, and D. Kvale Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms? Journal of Antimicrobial Chemotherapy 64 2009 901 909
41. G.A. McComsey, and U.A. Walker Role of mitochondria in HIV lipoatrophy: insight into pathogenesis and potential therapies Mitochondrion 4 2004 111 118 (Pubitemid 39549800)
42. R. Feeney Eoin, and W.G. Mallon Patrick Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulation Current Pharmaceutical Design 2010
43. H. Waki, and P. Tontonoz Endocrine functions of adipose tissue Annual Review of Pathology 2 2007 31 56 (Pubitemid 46448059)
44. S. Tsiodras, A. Perelas, and C. Wanke The HIV-1/HAART associated metabolic syndrome - novel adipokines, molecular associations and therapeutic implications Journal of Infection 61 2010 101 113
45. L.A. Kosmiski, P. Bacchetti, and D.P. Kotler Relationship of fat distribution with adipokines in human immunodeficiency virus infection The Journal of Clinical Endocrinology and Metabolism 93 2008 216 224
46. S.P. Jones, O. Janneh, and D.J. Back Altered adipokine response in murine 3T3-F442A adipocytes treated with protease inhibitors and nucleoside reverse transcriptase inhibitors Antiviral Therapy 10 2005 207 213 (Pubitemid 41151026)
47. C. Lagathu, B. Eustace, and M. Prot Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages Antiviral Therapy 12 2007 489 500 (Pubitemid 47041147)
48. S.P. Jones, N. Qazi, and J. Morelese Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens Journal of Acquired Immune Deficiency Syndromes 40 2005 565 572 (Pubitemid 41669161)
49. L.A. Nolte, K.E. Yarasheski, and K. Kawanaka The HIV protease inhibitor indinavir decreases insulin- and contraction-stimulated glucose transport in skeletal muscle Diabetes 50 2001 1397 1401 (Pubitemid 32500173)
50. R.A. DeFronzo, J.D. Tobin, and R. Andres Glucose clamp technique: a method for quantifying insulin secretion and resistance The American Journal of Physiology 237 1979 E214 E223
51. G.M. Behrens, A.R. Boerner, and K. Weber Impaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1-infected patients with lipodystrophy The Journal of Clinical Investigation 110 2002 1319 1327 (Pubitemid 35285758)
52. P.W. Hruz, H. Murata, and H. Qiu Indinavir induces acute and reversible peripheral insulin resistance in rats Diabetes 51 2002 937 942 (Pubitemid 34438334)
53. M.A. Noor, O.P. Flint, and J.F. Maa Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity: demonstrable differences in vitro and clinically AIDS 20 2006 1813 1821 (Pubitemid 44358899)
54. J.C. Shlay, F. Visnegarwala, and G. Bartsch Body composition and metabolic changes in antiretroviral-naive patients randomized to didanosine and stavudine vs. abacavir and lamivudine Journal of Acquired Immune Deficiency Syndromes 38 2005 147 155 (Pubitemid 40189321)
55. R.M. Blumer, M.G. van Vonderen, and J. Sutinen Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy AIDS 22 2008 227 236
56. A. Fleischman, S. Johnsen, and D.M. Systrom Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults American Journal of Physiology - Endocrinology And Metabolism 292 2007 E1666 E1673
57. D.E. Kelley, J. He, and E.V. Menshikova Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes Diabetes 51 2002 2944 2950
58. S.K. Gan, K. Samaras, and C.H. Thompson Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy Diabetes 51 2002 3163 3169 (Pubitemid 35246961)
59. L. Luzi, G. Perseghin, and G. Tambussi Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy American Journal of Physiology - Endocrinology And Metabolism 284 2003 E274 E280
60. S.R. Richmond, M.J. Carper, and X. Lei HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters Biochimica et Biophysica Acta 1801 2010 559 566
61. R.H. Unger, G.O. Clark, and P.E. Scherer Lipid homeostasis, lipotoxicity and the metabolic syndrome Biochimica et Biophysica Acta 1801 2010 209 214
62. Z. Gao, X. Zhang, and A. Zuberi Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes Molecular Endocrinology 18 2004 2024 2034 (Pubitemid 39006506)
63. S.B. Haugaard, O. Andersen, and S. Madsbad Skeletal muscle insulin signaling defects downstream of phosphatidylinositol 3-kinase at the level of Akt are associated with impaired nonoxidative glucose disposal in HIV lipodystrophy Diabetes 54 2005 3474 3483 (Pubitemid 43334338)
64. K. Rabe, M. Lehrke, and K.G. Parhofer Adipokines and insulin resistance Molecular Medicine 14 2008 741 751
65. G.A. Lee, J.C. Lo, and F. Aweeka Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers Clinical Infectious Diseases 43 2006 658 660 (Pubitemid 44267131)
66. G.A. Lee, D.D. Mafong, and M.A. Noor HIV protease inhibitors increase adiponectin levels in HIV-Negative men Journal of Acquired Immune Deficiency Syndromes 36 2004 645 647 (Pubitemid 38552377)
67. H.J. Woerle, P.R. Mariuz, and C. Meyer Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens Diabetes 52 2003 918 925 (Pubitemid 36384260)
68. M.P. Dube, H. Edmondson-Melancon, and D. Qian Prospective evaluation of the effect of initiating indinavir-based therapy on insulin sensitivity and B-cell function in HIV-infected patients Journal of Acquired Immune Deficiency Syndromes 27 2001 130 134 (Pubitemid 32595163)
69. J.C. Koster, M.S. Remedi, and H. Qiu HIV protease inhibitors acutely impair glucose-stimulated insulin release Diabetes 52 2003 1695 1700 (Pubitemid 36792459)
70. F.M. Matschinsky Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm Diabetes 45 1996 223 241 (Pubitemid 26045806)
71. Y. Neye, M. Dufer, and G. Drews HIV protease inhibitors: suppression of insulin secretion by inhibition of voltage-dependent K+ currents and anion currents The Journal of Pharmacology and Experimental Therapeutics 316 2006 106 112 (Pubitemid 41832586)
72. M. Schutt, J. Zhou, and M. Meier Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells The Journal of Endocrinology 183 2004 445 454 (Pubitemid 40057575)
73. S. Chandra, D. Mondal, and K.C. Agrawal HIV-1 protease inhibitor induced oxidative stress suppresses glucose stimulated insulin release: protection with thymoquinone Experimental Biology and Medicine (Maywood, N.J.) 234 2009 442 453
74. S. Zhang, M.J. Carper, and X. Lei Protease inhibitors used in the treatment of HIV+ induce beta-cell apoptosis via the mitochondrial pathway and compromise insulin secretion American Journal of Physiology - Endocrinology And Metabolism 296 2009 E925 E935
75. M. van der Valk, P.H. Bischop, and J.A. Romijn Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways AIDS 15 2001 2093 2100 (Pubitemid 33101816)
76. J.M. Schwarz, G.A. Lee, and S. Park Indinavir increases glucose production in healthy HIV-negative men AIDS 18 2004 1852 1854 (Pubitemid 39179640)
77. M. Schutt, M. Meier, and M. Meyer The HIV-1 protease inhibitor indinavir impairs insulin signalling in HepG2 hepatoma cells Diabetologia 43 2000 1145 1148
78. R. Burcelin, W. Dolci, and B. Thorens Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice Diabetes 49 2000 1643 1648
79. C. Buettner, and R.C. Camacho Hypothalamic control of hepatic glucose production and its potential role in insulin resistance Endocrinology and Metabolism Clinics of North America 37 2008 825 840
80. S. El Messari, C. Leloup, and M. Quignon Immunocytochemical localization of the insulin-responsive glucose transporter 4 (Glut4) in the rat central nervous system The Journal of Comparative Neurology 399 1998 492 512 (Pubitemid 28411112)
81. M. Bongiovanni, and F. Tordato Steatohepatitis in HIV-infected subjects: pathogenesis, clinical impact and implications in clinical management Current HIV Research 5 2007 490 498
82. E. Fabbrini, S. Sullivan, and S. Klein Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications Hepatology 51 2010 679 689
83. V.T. Samuel, Z.X. Liu, and X. Qu Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease Journal of Biological Chemistry. 279 2004 32345 32353 (Pubitemid 39014687)
84. Standards of medical care in diabetes-2010 Diabetes Care 33 Suppl. 1 2010 S11 S61